CANC 5578 (B9991010) (Javelin100)

Trial description
A randomised, open-label, multicentre, phase 3 study to evaluate the efficacy and safety of Avelumab (MSB0010718C) in combination with and/or following chemotherapy in patients with previously untreated epithelial ovarian cancer
Contact name
Dr Christine Parkinson
Trial start date
Tuesday, May 31, 2016
Trial end date
Wednesday, August 28, 2019
Trial tumour type
Show on Radiotherapy